Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

PHARMACIST - BCPA: New Drugs of 2019


Date: Jan 22, 2020 07:00 PM - 07:45 PM

Location: UIW Feik School of Pharmacy, 703 E. Hildebrand, San Antonio, TX, 78212

CE Hours

1.00

CE Units

0.100

Registration closes on Mar 04, 2020 11:55 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

 
 
 
 
 
Accreditation Council for Pharmacy Education
The University of the Incarnate Word Feik School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
 
 
 
 

Joint Provider(s)

Bexar County Pharmacy Association (BCPA)

Requirements for CE Credit

  • The participant will only receive credit for programs after receiving a 70% on a post-test and an evaluation form is completed and submitted. 
  • The entire session must be attended to receive credit. No partial credit will be given. 
  • Certificates will not be mailed. Contact hours will be uploaded to NABP's CPE Monitor after successful completion of post-test and program evaluation. 
  • To receive credit, participant profiles must contain a valid NABP e-profile ID number and month/date of birth. 
  • All requirements to receive credit must be completed within six weeks of participation in the CPE program. Failure to complete requirements within the six-week window will result in no credit awarded to the participant. 

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

Registration closes on Mar 04, 2020 at 11:55 PM

Registration Closed  

Upon completion of this activity, participants will be able to:
  1. List new therapeutic agents that were approved by the Food and Drug Administration in 2019.
  2. Describe the mechanisms of action and indications for new therapeutic drugs.
  3. Compare and contrast the new therapeutic agents with products available with similar indications.
  4. Discuss important patient education and therapeutic monitoring parameters for new therapeutic agents.
  5. Summarize the adverse effects and patient safety considerations for new therapeutic agents.
 
 

Speaker(s)/Author(s)

Amy Lugo

Zachary Leftwich

Activity Number

0445-9999-20-001-L01-P
Date: 01/22/20
Time: 07:00 PM - 07:45 PM

CE Hours

1.00

Location

FSOP 533 (P3 Classroom)
Registration Closed